Jump to content


Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Photo

Mycophenolic acid in Rheumatology: mechanisms of action and severe adverse events


  • Please log in to reply
No replies to this topic

#1 CraigR

CraigR

    Senior Silver Member

  • Members
  • PipPipPipPipPip
  • 394 posts
  • Location:Escondido (near San Diego), Ca

Posted 24 August 2010 - 02:11 AM

Mycophenolic acid in Rheumatology: mechanisms of action and severe adverse events. Mycophenolic acid (MPA) is an immunosuppressive agent, more and more extensively used in transplantation, rheumatology and nephrology. In this review, we will analyze the molecular mechanisms of its action. G. Zizzo. (PubMed) Reumatismo. 2010;62(2):91-100. (Also see: Mycophenolate mofetil (Cellcept))

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Craig Roothoff
ISN Assistant News Guide
International Scleroderma Network(ISN)